Skip to Main Content

INFORMATION FOR

A. David Paltiel, MBA, PhD

Professor of Public Health (Health Policy), Professor of Management, and Professor in the Institution for Social and Policy Studies; Co-director, Public Health Modeling Concentration; Affiliated Faculty, Yale Institute for Global Health

Research Summary

The objective that guides Dr. Paltiel's scholarly activities is to promote a reasoned approach to choices under uncertainty and resource scarcity in health and medicine. Trained in the field of Operations Research, Dr. Paltiel designs and implements model-based cost-effectiveness analyses of medical technologies and public health interventions. His published research, including more than 100 peer-reviewed papers, spans both methods development and applications to a wide range of disease areas and clinical specialties. He has a special interest and expertise in HIV/AIDS and has published broadly on the cost-effectiveness of testing, prevention, treatment, and care, both in the United States and around the world.

Among the many talented modelers at Yale, Dr. Paltiel's unique contribution lies in bringing a decision-analytic and cost-effectiveness overlay to public health policy and resource allocation. His expertise in both the theory of choice under uncertainty and its practical adaptation to policy-relevant applications provides substantial opportunity to mentor colleagues interested in promoting a more reasoned approach to clinical practice and priority setting in health and medicine.

Specialized Terms: Operations research; Disease simulation modeling

Extensive Research Description

  1. Novel approaches to the design and evaluation of combination HIV prevention. The goals of this NIMH-funded grant project are to develop and illustrate three novel ways of thinking about HIV prevention program design and evaluation: viewing HIV prevention in terms of policy bundles; looking beyond program cost-effectiveness to program affordability; and designing financial incentives that translate into better long-term HIV outcomes. The broad objective that guides this research is to squeeze the greatest possible benefit out of every HIV prevention dollar.
  2. Economic Modeling for HIV, Viral Hepatitis, STD, TB and School Health. The goal of this CDC-funded collaborative grant to the Harvard School of Public Health (Principal Investigator: Joshua Salomon) is to conduct health and economic modeling to inform decision-making on HIV, hepatitis, STD, TB and school health at national, state and local levels, in partnership with the National Center for HIV/AIDS Viral Hepatitis, STD and TB Prevention.
  3. Cost-Effectiveness of Preventing AIDS Complications (CEPAC-US). The goal of this NIAID-funded collaborative grant to Massachusetts General Hospital (Principal Investigator: Kenneth Freedberg) is to develop a computer simulation model of advanced HIV disease and use to project the costs and consequences of alternative patient care strategies.
  4. Optimizing HIV Care in Less Developed Countries (CEPAC-International). The goal of this NIAID-funded collaborative grant to Massachusetts General Hospital (Principal Investigator: Kenneth Freedberg) is to provide mentoring for young investigators in patient-oriented HIV research and use ongoing HIV simulation model in conjunction with mentoring efforts to address critical HIV clinical management questions in the US and internationally.
  5. Making Better Decisions: Policy Modeling for AIDS & Drug Abuse. The goal of this NIDA-funded collaborative grant to Stanford University (Principal Investigator: Douglas Owens) is to develop and apply mathematical policy modeling techniques to the evaluation of AIDS‑related public health interventions.
  6. Novel Methods to Inform HIV/TB Clinical Trial Development. The goals of this NIAID-funded collaborative grant (Principal Investigator: Rochelle Walensky) are to apply a mathematical simulation modeling framework, based on the Cost-Effectiveness of Preventing AIDS Complications (CEPAC) Model, to the NIAID/ACTG clinical trials infrastructure. We propose to inform the development, design, and assessment of therapeutic, diagnostic, and 'strategy' clinical trials in HIV/TB care in international settings. The ultimate goal of this project is to apply novel scientific methods in a highly innovative fashion, to maximize trial investments. It will develop new scientific knowledge of value to HIV/TB investigators, as well as clinical trialists in many areas of medicine.
  7. Typhoid modeling studies for typhoid conjugate vaccine cost effectiveness and for typhoid delivery strategy. The goals of this project, funded by a grant from the Bill & Melinda Gates Foundation (Principal Investigator: Virginia E. Pitzer), are to conduct research aimed toward the prevention of HIV infection and the reduction of the negative consequences of HIV disease in vulnerable and underserved populations in the U.S.
  8. A unified intervention for young gay and bisexual men's minority stress, mental health, and HIV risk. The goals of this NIMH-funded grant (Principal Investigator: John Pachankis) are to address key sources of HIV risk among MSM, including stigma-related stress and associated mental health and substance use difficulties, and to use the intervention developed in this project to reduce HIV risk behavior among MSM and therefore the spread of HIV.
  9. Improving HIV Prevention and Treatment in Ukraine through Innovations in Healthcare Integration for People Who Inject Drugs. The goals of this NIDA-funded grant (Principal Investigator: Frederick L. Altice) are to use a multi-level, implementation science framework and multi-site cluster design to compare Quality of Health Indicator outcomes in PWIDs treated in integrated primary care centers with those who receive standard of care.

Coauthors

Research Interests

Acquired Immunodeficiency Syndrome; France; Health Policy; Health Resources; HIV; India; Operations Research; South Africa

Public Health Interests

Community Health; Health Care Management; Health Policy; HIV/AIDS; Infectious Diseases; Mental Health; Substance Use, Addiction; Health Equity, Disparities, Social Determinants and Justice; COVID-19

Selected Publications

  • Population-level strategies for nirmatrelvir/ritonavir prescribing - a cost-effectiveness analysisSavinkina A, Paltiel A, Ross J, Gonsalves G. Population-level strategies for nirmatrelvir/ritonavir prescribing - a cost-effectiveness analysis Open Forum Infectious Diseases 2022 DOI: 10.1093/ofid/ofac637.
  • VALUE OF USING GABAPENTIN FOR KNEE OA PATIENTS: A COST-EFFECTIVENESS ANALYSIS.Bensen G, Rogers A, Leifer V, Edwards R, Neogi T, Kostic A, Paltiel A, Collins J, Hunter D, Katz J, Losina E. VALUE OF USING GABAPENTIN FOR KNEE OA PATIENTS: A COST-EFFECTIVENESS ANALYSIS. Osteoarthritis And Cartilage 2022, 30: s261-s262. DOI: 10.1016/j.joca.2022.02.357.
  • THU-391-Impact of early screening and treatment of hepatitis C virus and improvements in risk reduction on HCV transmission among HIV-infected men who have sex with men in France: A modeling approachCastry M, Cousien A, Supervie V, Velter A, Ghosn J, Paltiel A, Yazdanpanah Y, Deuffic-Burban S. THU-391-Impact of early screening and treatment of hepatitis C virus and improvements in risk reduction on HCV transmission among HIV-infected men who have sex with men in France: A modeling approach Journal Of Hepatology 2019, 70: e327. DOI: 10.1016/s0618-8278(19)30639-5.
  • 2000. Rapid, Point-of-care Diagnosis of Tuberculosis with Novel Truenat Assay: Cost-Effectiveness and Budgetary Impact Analysis for India’s Public SectorLee D, Kumarasamy N, Resch S, Sivaramakrishnan G, Mayer K, Tripathy S, Paltiel A, Freedberg K, Reddy K. 2000. Rapid, Point-of-care Diagnosis of Tuberculosis with Novel Truenat Assay: Cost-Effectiveness and Budgetary Impact Analysis for India’s Public Sector Open Forum Infectious Diseases 2018, 5: s582-s582. PMCID: PMC6254532, DOI: 10.1093/ofid/ofy210.1656.
  • The Inclusion Body Myositis Registry at Yale: A growing information database and practical tool for researchers, clinicians, and patientsCotzomi E, Petschke K, O'Connor K, Paltiel A. The Inclusion Body Myositis Registry at Yale: A growing information database and practical tool for researchers, clinicians, and patients Muscle & Nerve 2017 DOI: 10.1002/mus.25774.
  • Prioritizing HIV comparative effectiveness trials based on value of information: generic versus brand-name ART in the USPei P, Weinstein M, Li X, Hughes M, Paltiel A, Hou T, Parker R, Gaynes M, Sax P, Freedberg K, Schackman B, Walensky R. Prioritizing HIV comparative effectiveness trials based on value of information: generic versus brand-name ART in the US HIV Research & Clinical Practice 2015, 1945577115y.000. DOI: 10.1179/1945577115y.0000000009.
  • Could nerve growth factor inhibitors have a place in the treatment of knee osteoarthritis?: Impact of joint destruction and means of administration ossn the value of TanezumabsLosina E, Michl G, Collins J, Hunter D, Jordan J, Yelin E, Paltiel A, Katz J. Could nerve growth factor inhibitors have a place in the treatment of knee osteoarthritis?: Impact of joint destruction and means of administration ossn the value of Tanezumabs Osteoarthritis And Cartilage 2015, 23: a394. DOI: 10.1016/j.joca.2015.02.727.
  • Track C Epidemiology and Prevention ScienceRaugi D, Gottlieb G, Sow P, Cherne S, Toure M, Sall F, Traore F, Sy M, Zheng N, N'Doye I, Kiviat N, Hawes S, Group U, Messeri P, Chiasson M, Kall M, Smith R, Brown A, Delpech V, Eritsyan K, Levina O, Smolskaia T, White E, Heimer R, de Vos A, van der Helm J, Prins M, Kretzschmar M, Hontelez J, de Vlas S, Baltussen R, Bakker R, Tanser F, Lurie M, Bärnighausen T, Powers K, Ghani A, Miller W, Hoffman I, Pettifor A, Hosseinipour M, Kamanga G, Martinson F, Cohen M, Dimitrov D, Boily M, Marrazzo J, Brown E, Qian H, Lou J, Ruan Y, Webb G, Shao Y, Vermund S, Morris M, Evans J, Yu M, Briceno A, Page K, Hahn J, Patel S, Schechter M, Muyinda H, Kiwanuka N, Sewankambo N, Spittal P, Fichorova R, Morrison C, Doncel G, Chen P, Kwok C, Chipato T, Salata R, Mauck C, Heffron R, Donnell D, Rees H, Celum C, Mugo N, Were E, de Bruyn G, Nakku‐Joloba E, Ngure K, Kiarie J, Coombs R, Baeten J, Team P, Polis C, Curtis K, Phillips S, Curtis K, Polis C, Beer L, Oster A, Mattson C, Skarbinski J, Kahle E, Campbell M, Lingappa J, Donnell D, Celum C, Kapiga S, Ondondo R, Mugo N, Mujugira A, Fife K, Mullins J, Baeten J, Study P, Bearnot B, Werner L, Kharsany A, Karim S, Frohlich J, Karim Q, Mapanje C, Rutstein S, Kamanga G, Phiri S, Nsona D, Pettifor A, Rosenberg N, Hoffman I, Miller W, Crane H, Mimiaga M, Feldman B, Fredericksen R, Mugavero M, Willig J, Safren S, Matthews W, Christopoulos K, Boswell S, Kitahata M, Saag M, Mayer K, Systems C, Hesseling A, Passmore J, Gamieldien H, Jones C, Hanekom W, Sodora D, Jaspan H, Hall H, Frazier E, Rhodes P, Holtgrave D, Furlow‐Parmley C, Tang T, Gray K, Cohen S, Skarbinski J, Fishel J, Bradley S, Young P, Mbofana F, Botao C, Zaidi J, Grapsa E, Tanser F, Newell M, Bärnighausen T, Van Renterghem H, Colvin M, de Beer I, Gunthorp J, Odiit M, Thomas L, Jackson H, Getahun M, Grady B, van der Knaap N, van der Loeff M, Heijman T, Speksnijder A, Geskus R, Prins M, Meade C, Watt M, Sikkema K, Deng L, Ranby K, Skinner D, Pieterse D, Kalichman S, Peinado J, Lama J, Gonzales P, Cabello R, Rosas G, Sanchez J, Cao X, Wu Z, Rou K, Pang L, Baral S, Beyrer C, Muessig K, Poteat T, Wirtz A, Decker M, Sherman S, Kerrigan D, Shannon K, Akello M, Muldoon K, Simo A, Muzaaya G, Rosenberg E, Kelley C, O'Hara B, Frew P, Peterson J, Sanchez T, del Rio C, Sullivan P, Oster A, Russell K, Wiegand R, Le B, Valverde E, Forrest D, Cribbin M, Paz‐Bailey G, Group N, Oster A, Johnson C, Le B, Finlayson T, Balaji A, Lansky A, Mermin J, Valleroy L, MacKellar D, Behel S, Paz‐Bailey G, Groups Y, Mayer K, Wang L, Koblin B, Mao C, Mannheimer S, Magnus M, del Rio C, Buchbinder S, Wilton L, Cummings V, Watson C, Griffith S, Wheeler D, Team H, Koblin B, Mayer K, Eshleman S, Wang L, Shoptaw S, del Rio C, Buchbinder S, Magnus M, Mannheimer S, Liu T, Cummings V, Piwowar‐Manning E, Fields S, Griffith S, Elharrar V, Wheeler D, Team H, Mellouk O, Alami K, Rhilani H, Rafif N, Abadie A, Ouarsas L, Bennani A, Omari B, Oumzil I, Johnston L, Rangsin R, Kana K, Chuenchitra T, Sunantarod A, Meesiri S, Areekul W, Nelson K, Khobragade S, Goswami P, Ramakrishnan L, George B, Adhikary R, Ramanathan S, Mathew S, Kumar R, Kodali V, Wirtz A, Trapence G, Jumbe V, Umar E, Ketende S, Kamba D, Berry M, Stromdahl S, Beyrer C, Baral S, Metsch L, Kuo I, Lalota M, Phillips G, Cardenas G, Castel A, Forrest D, West T, Pereyra M, Jia Y, Kolber M, Opoku J, Magnus M, Elkamhawi S, Abaza O, Elghamrawy E, Elmagd S, Ramy H, Atallah S, Elkot N, Kamal M, Mawazini F, Helmy R, Soliman C, Pharris A, Noori T, Likatavicius G, van de Laar M, Baral S, Poteat T, Wirtz A, Stromdahl S, Beyrer C, Okuku H, Wahome E, Duncan S, Thiongo’ A, Mwambi J, Shafi J, Smith A, Graham S, Sanders E, Taylor M, Schillinger J, Pathela P, Skinner J, Newman D, Braunstein S, Shepard C, Brewer T, Ahmed T, Griffin A, Furness B, Cope A, Crooks A, Kuruc J, Sugarbaker A, Hightow‐Weidman L, Eron J, Gay C, Lee S, Roehler M, Guillon G, Schiff E, Delgado‐Borrego A, Friel T, La Marca A, Dickson R, Sulkowski M, Borders J, Allen G, Kurtz L, Kardos K, Gregg R, Muro F, Fiorillo S, Odhiambo C, Cunningham C, Buchanan A, Urbanus A, van de Laar T, Geskus R, Vanhommerig J, van Rooijen M, Schinkel J, Heijman T, Coutinho R, Prins M, Dong Y, Qiu C, Xia X, Wang J, Zhang H, Wang Y, Zhang X, Xu J, Chu P, Santos G, Vu A, Nieves‐Rivera I, Colfax G, Grinsdale J, Huang S, Philip S, Scheer S, Aragon T, Sey K, Ma Y, Song N, Nunes E, Maricato J, Zukurov J, Janini L, Vidanapathirana H, Sangeeth M, Rowan S, Johnson S, Thrun M, Daniloff E, Reirden D, Burman W, Connick E, Gardner E, Mitchell K, Foss A, Prudden H, Pickles M, Williams J, Johnson H, Ramesh B, Washington R, Isac S, Rajaram S, Phillips A, Bradley J, Alary M, Moses S, Lowndes C, Watts C, Boily M, Vickerman P, Wirtz A, Pretorius C, Sherman S, Baral S, Decker M, Sweat M, Beyrer C, Kerrigan D, Suryawanshi D, Swain P, Kumari R, Bhatnagar T, Zhou W, Bharat S, Bhattacharya M, Pandey A, Collumbien M, Marshall B, Paczkowski M, Tempalski B, Pouget E, Friedman S, Galea S, Kessler J, Myers J, Nucifora K, Mensah N, Kowalski A, Sweeney M, Toohey C, Shepard C, Cutler B, Braithwaite S, Tripathi A, Whiteside O, Scanlon C, Duffus W, Marshall B, Paczkowski M, Seemann L, Tempalski B, Pouget E, Galea S, Friedman S, Ahmed T, Griffin A, West T, Pappas G, Metsch L, Pollack H, Abel S, Kunzel C, Greenberg B, Messinger S, Pereyra M, Schouten E, Sinunu M, Wadonda N, Kajawo E, Eliya M, Chimbwandira F, Kellerman S, Lin H, He N, Ding Y, Zhu W, Detels R, Juárez‐Figueroa L, Gonzalez‐Rodríguez A, Casillas J, Rodríguez‐Nolasco E, Iracheta P, Laeyendecker O, Brookmeyer R, Cousins M, Mullis C, Konikoff J, Donnell D, Celum C, Buchbinder S, Seage G, Kirk G, Mehta S, Astemborski J, Jacobson L, Margolick J, Brown J, Quinn T, Eshleman S, Reed J, Justman J, Bicego G, Donnell D, Bock N, Ginindza H, Koler A, Philip N, Makhanya M, Mlambo C, Parekh B, Duong Y, Ellenberger D, Sexton C, Nkambule R, Aghaizu A, Kall M, Smith R, Tosswill J, Murphy G, Delpech V, Kretzschmar M, van der Loeff M, De Angelis D, Coutinho R, Hontelez J, Lurie M, Bärnighausen T, Bakker R, Baltussen R, Tanser F, Hallett T, Newell M, de Vlas S, Walensky R, Ross E, Kumarasamy N, Wood R, Noubary F, Paltiel A, Nakamura Y, Godbole S, Hosseinipour M, Hakim J, Kumwenda J, Makhema J, Akelo V, Panchia R, Sanne I, Weinstein M, Losina E, Mayer K, Grinsztejn B, Pilotto J, Chariyalertsak S, Santos B, Chen Y, Wang L, Li X, McCauley M, Gamble T, Piwowar‐Manning E, Cottle L, Hoffman I, Eron J, Gallant J, Swindells S, Taha T, Nielsen‐Saines K, Celentano D, Essex M, Elharrar V, Burns D, Seage G, Cohen M, Freedberg K, Stover J, Pretorius C, Kato M, Granich R, Vu H, Nadol P, Sabin K, Suthar A, Williams B, Mayer K, Wang L, Hoffman I, McCauley M, Li X, Safren S, Gamble T, Talley J, Cottle L, Piwowar‐Manning E, Akelo V, Badal‐Faesen S, Chotirosniramit N, Fernandes N, Kumarasamy N, Sahay S, Makhema J, Panchia B, Pilotto J, Santos B, Cohen M, McGrath N, Eaton J, Tanser F, Bärnighausen T, Newell M, Bennett D, Jordan M, Bertagnolio S, Hong S, Ravasi G, McMahon J, Kelley K, McMahon J, Elliott J, Hong S, Jordan M, Evans D, Maskew M, Fox M, McNamara L, MacPhail P, Mathews C, Sanne I, Koole O, Tsui S, Wabwire‐Mangen F, Kwesigabo G, Menten J, Mulenga M, Auld A, Agolory S, Mukadi Y, Colebunders R, Bangsberg D, Van Praag E, Torpey K, Williams S, Kaplan J, Zee A, Denison J, Lamb M, Eduardo E, Kandula S, Howard A, Sadr W, Mugisha V, Kimanga D, Kilama B, Elul B, Delpech V, Yin Z, Kall M, Brown A, Benbow N, Scheer S, Wohl A, Brady K, Gagner A, Hughes A, Tejero J, Eberhart M, Hu V, Sayles J, Townsell S, Willis S, Castel A, Griffin A, West T, Shaikh I, Pappas G, Halldorsdottir I, Taruberekera N, Capo‐Chichi V, Firestone R, Vu L, Sherard D, Harrison R, Chan S, Yang B, Wolverton M, Arafat R, Althoff K, Buchacz K, Hall I, Zhang J, Hanna D, Rebeiro P, Gange S, Moore R, Kitahata M, Gebo K, Martin J, Justice A, Horberg M, Hogg R, Sterling T, Cescon A, Klein M, Thorne J, Crane H, Mugavero M, Napravnik S, Kirk G, Jacobson L, Rodriguez B, Brooks J, Research and Design N, Gebre Y, Jack N, Edwards P, Del Riego A, Caffe S, Koul R, Vyas D, Stoové M, Bowring A, Luhmann N, Debaulieu C, Stéphanie D, Pont S, Assouab F, Abdalla T, van Gemert C, Dietze P, Kikumbih N, Nielsen‐Bobbit J, Mbandi A, Motta W, Killian R, Mwanga F, Singh S, Lampe M, Babu A, Rao S, Borkowf C, Nesheim S, Mohammed S, Gupta R, Rao R, Joseph V, Srikantiah P, Kohler P, Okanda J, Kinuthia J, Olilo G, Odhiambo F, Mills L, Kayla L, John‐Stewart G, Kanjipite W, Nikisi J, Chilila M, Shasulwe H, Banda J, Mulilo J, Smit J, Hoffman S, Mabude Z, Beksinska M, Stein Z, Ngoloyi C, Kelvin E, Masvawure T, Pienaar J, Leu C, Exner T, Mantell J, Burgos J, Patterson T, Graff‐Zivin J, Kahn J, Rangel M, Ojeda V, Lozada M, Strathdee S, Adipo T, Westercamp N, Agot K, Jaoko W, Bailey R, Mehta S, Li H, Moses S, Agot K, Maclean I, Hedeker D, Bailey R, Auvert B, Taljaard D, Sitta R, Reach D, Lissouba P, Bouscaillou J, Singh B, Shabangu D, Nhlapo C, Darko J, Mashigo T, Taljaard R, Phatedi G, Tsepe M, Chakela M, Mkhwanazi A, Ntshangase P, Peytavin G, Billy S, Puren A, Lewis D, Sokal D, Awori Q, Barone M, Simba R, Bowa K, Zulz R, Cherutich P, Muraguri N, Wekesa J, Moguche J, Kasonde P, Lee R, Masson P, Perchal P, Combes S, Hart C, Goldstein M, Li P, Vincent M, Kaplan S, Bitega J, Ngeruka M, Karema C, Binagwaho A, Mwandi Z, Ochieng A, Grund J, Mwalili S, Kimanga D, Otieno G, Ohaga S, Oyaro P, Mwangi C, Knight N, Chesang K, Bock N, Reed J, Mirira M, Grund J, Nqeketo A, Ginindza H, Donnell D, Nkambule R, Bicego G, Ryan C, Justman J, Stoové M, El‐Hayek C, Fairley C, Goller J, Leslie D, Roth N, Tee B, Denham I, Chen M, Hellard M, van Aar F, van Weert Y, Spijker R, Götz H, de Coul E, Valverde E, Dinenno E, Oster A, Chavez P, Thomas P, Schulden J, Heffelfinger J, Kahle E, Donnell D, James H, Thomas K, John‐Stewart G, Nakku‐Joloba E, Bukusi E, Lingappa J, Celum C, Baeten J, Study P, Krakower D, Mimiaga M, Rosenberger J, Novak D, Mitty J, White J, Mayer K, Yang D, Chariyalertsak C, Wongthanee A, Kawichai S, Yotruean K, Guadamuz T, Suwanvanichkij V, Beyrer C, Chariyalertsak S, Coleman J, Chaturvedula A, Hendrix C, Team M, van de Vijver D, Nichols B, Abbas U, Cambiano V, Eaton J, Glaubius R, Lythgoe K, Mellors J, Phillips A, Sigaloff K, Hallett T, Mark D, Amico K, Wallace M, Roux S, Grant R, Wood R, Bekker L, Urbina A, Osorio G, Daniel E, Galatowitsch P, Riggan B, Hennessey Z, Sharp V, Underhill K, Morrow K, Operario D, Ducharme R, Kuo C, Mayer K, Smith T, Willis R, Malone A, Moss J, Baum M, Vincent K, Motamedi M, Kennedy S, Gilman J, Butkyavichene I, Nguyen C, Smith T, Malone A, Moss J, Willis R, Baum M, Gilman J, Butkyavichene I, Kennedy S, Nguyen C, Smith T, Massud I, Aung W, Martin A, Bachman S, Mitchell J, Deyounks F, Kersh E, Pau C, Heneine W, Garcia‐Lerma J, Birungi J, Wang H, Ngolobe M, Muldoon K, Khanakwa S, King R, Kaleebu P, Shannon K, Ochai R, Montaner J, Mills E, Laurenco L, Abdallar N, Moore D, Kamwi R, Hamunime N, Odiit M, Gweshe J, Muadinohamba A, Shihepo E, Van Renterghem H, Jonas A, De Klerk M, Mahy M, Forster N, Kahuure K, Anglemyer A, Rutherford G, Baggaley R, Egger M, Siegfried N, Udeagu C, Webster‐León T, Bocour A, Michel P, Shepard C, Holt M, Murphy D, Callander D, Ellard J, Rosengarten M, Kippax S, de Wit J, Gari S, Musheke M, Ntalasha H, Malungo J, Merten S, Ti L, Hayashi K, Kaplan K, Suwannawong P, Montaner J, Wood E, Kerr T, Rimal R, Mkandawire G, Dothi W, Roberts P, Brown J, Limaye R, Cluver L, Orkin M, Boyes M, Kuo C, Gardner F, Kganakga M, Limba J, Dupas P, Sharma V, Makana G, Nekesa C, Duflo E, Tiffany J, Eckenrode J, Exner‐Cortens D, Birnel‐Henderson S, Khan A, Qazi R, Nazim N, Khan A, Wilson D, Zhang L, Kerr C, Kwon A, Hoare A, Williams‐Sherlock M, Avila C, group E, Zule W, Cross H, Go V, Frangakis C, Le M, Viet H, Latkin C, Thi M, Sripaipan T, Davis W, Pham The V, Minh Q, Njenga F, Kiima D, Siminyu M, Munyi E, Abdool R, Muthui M, Lambdin B, Mbwambo J, Mwamburi E, McCurdy S, Pick B, Anderson G, Mital S, Needle R, Carballo‐Diéguez A, Balan I, Frasca T, Dolezal C, Valladares J, Derendinger S, Staub R, Habarta N, Wang G, Mulatu M, Ramakrishnan L, Goswami P, Subramaniam T, Mathew S, Ramanathan S, George B, Adhikary R, Mainkar M, Paranjape R, Brown A, Aghaizu A, Murphy G, Delpech V, Brown A, Gill O, Presanis A, Delpech V, Murphy G, Nicca D, Rasi M, Stoelzl S, Schmid P, Kahlert C, Vernazza P, Study S, Yin L, Wang N, Ruan Y, Shao Y, Vermund S, Qian H, Jones R, Lacroix L, Hoover D, Sivalenka S, Mallachar C, Chava L, Ravi S, Berg R, Ross M, Schmidt A, Weatherburn P, Network E, Robertson L, Mushati P, Eaton J, Dumba L, Mavise G, Makoni J, Schumacher C, Crea T, Monasch R, Sherr L, Garnett G, Nyamukapa C, Gregson S, Tepper V, Kriebs J, Lovelace S, Nair P, Voetsch A, Anderson M, Machakaire E, Bodika S, Jimbo W, Yadav B, Schaan M, Madidimalo T, Lebelonyane R, Webb K, Patel D, Mujaranji G, Engelsmann B, Weber S, Waldura J, Cohan D. Track C Epidemiology and Prevention Science Journal Of The International AIDS Society 2012, 15: 18440-001. PMCID: PMC3501674, DOI: 10.7448/ias.15.5.18440.
  • 355 DISEASE MODIFYING DRUGS IN KNEE OSTEOARTHRITIS: CAN THEY BE COST-EFFECTIVE?Losina E, Losina E, Niu N, Niu N, Suter L, Hunter D, Hunter D, Holt H, Holt H, Gerlovin H, Gerlovin H, Reichmann W, Reichmann W, Solomon D, Solomon D, Walensky R, Walensky R, Paltiel A, Katz J, Katz J. 355 DISEASE MODIFYING DRUGS IN KNEE OSTEOARTHRITIS: CAN THEY BE COST-EFFECTIVE? Osteoarthritis And Cartilage 2009, 17: s187-s188. DOI: 10.1016/s1063-4584(09)60377-0.
  • ReplyWu A, Paltiel A, Kuntz K, Weiss S, Fuhlbrigge A. Reply Journal Of Allergy And Clinical Immunology 2008, 121: 1514-1515. DOI: 10.1016/j.jaci.2008.01.073.
  • Impact of Expanded HIV ScreeningPaltiel A, Walensky R, Freedberg K. Impact of Expanded HIV Screening Annals Of Internal Medicine 2007, 147: 146. DOI: 10.7326/0003-4819-147-2-200707170-00019.
  • An Asthma Policy ModelPaltiel A, Kuntz K, Weiss S, Fuhlbrigge A. An Asthma Policy Model 2005, 70: 659-693. DOI: 10.1007/1-4020-8066-2_26.
  • Age does not limit quality of life improvement in cardiac valve surgerySedrakyan A, Vaccarino V, Paltiel A. Age does not limit quality of life improvement in cardiac valve surgery ACC Current Journal Review 2004, 13: 60. DOI: 10.1016/j.accreview.2003.10.005.
  • PRPI 9: BONE MINERAL DENSITY LOSS AFFECTS ESTIMATES OF THE COSTEFFECTIVENESS OF INHALED STEROIDS IN ASTHMAPaltiel A, Fuhlbrigge A, Kitch B, Rashti R, Weiss S, Lee S, Kuntz K. PRPI 9: BONE MINERAL DENSITY LOSS AFFECTS ESTIMATES OF THE COSTEFFECTIVENESS OF INHALED STEROIDS IN ASTHMA Value In Health 2003, 6: 369. DOI: 10.1016/s1098-3015(10)64272-6.
  • The Cost-Effectiveness of Treatment for Varicocele Related InfertilityPENSON D, PALTIEL A, KRUMHOLZ H, PALTER S. The Cost-Effectiveness of Treatment for Varicocele Related Infertility Investigative Urology 2002, 168: 2490-2494. DOI: 10.1097/00005392-200212000-00033.
  • RS4: A MODEL-BASED EVALUATION OF INHALED STEROIDS IN MILD-TO-MODERATE ASTHMAPaltiel A, Fuhlbrigge A, Kitch B, Weiss S, Neumann P, Kuntz K. RS4: A MODEL-BASED EVALUATION OF INHALED STEROIDS IN MILD-TO-MODERATE ASTHMA Value In Health 2001, 4: 65-66. DOI: 10.1046/j.1524-4733.2001.40201-48.x.
  • Model-Based Drug Evaluation in Chronic Disease: Promise, Pitfalls, and Positioning*Paltiel A. Model-Based Drug Evaluation in Chronic Disease: Promise, Pitfalls, and Positioning* Therapeutic Innovation & Regulatory Science 2001, 35: 131-139. DOI: 10.1177/009286150103500114.
  • A Model of HIV Patient Care: Methods and Applications to the Cost-Effectiveness of Anti-Viral TherapyPaltiel A, Goldie S, Seage G, Losina E, Weinstein M, Cohen C, Craven D, Freedberg K. A Model of HIV Patient Care: Methods and Applications to the Cost-Effectiveness of Anti-Viral Therapy Sexually Transmitted Diseases 2000, 27: 650-651. DOI: 10.1097/00007435-200011000-00026.
  • Acute Scrotal Symptoms in Boys With an Indeterminate Clinical Presentation: Comparison of Color Doppler Sonography and ScintigraphyPaltiel H, Connolly L, Atala A, Paltiel A, Zurakowski D, Treves S. Acute Scrotal Symptoms in Boys With an Indeterminate Clinical Presentation: Comparison of Color Doppler Sonography and Scintigraphy Investigative Urology 1999, 161: 1408. DOI: 10.1016/s0022-5347(01)61728-2.
  • Acute Scrotal Symptoms in Boys With an Indeterminate Clinical PresentationPaltiel H, Connolly L, Atala A, Paltiel A, Zurakowski D, Treves S. Acute Scrotal Symptoms in Boys With an Indeterminate Clinical Presentation Investigative Urology 1999, 161: 1408.. DOI: 10.1097/00005392-199904000-00140.
  • Acute Scrotal Symptoms in Boys With an Indeterminate Clinical Presentation: Comparison of Color Doppler Sonography and ScintigraphyPaltiel J, Connolly L, Atala A, Paltiel A, Zurakowski D, Treves S. Acute Scrotal Symptoms in Boys With an Indeterminate Clinical Presentation: Comparison of Color Doppler Sonography and Scintigraphy Investigative Urology 1998, 160: 1597-1598. DOI: 10.1016/s0022-5347(01)62655-7.
  • Acute Scrotal Symptoms in Boys With an Indeterminate Clinical PresentationPaltiel J, Connolly L, Atala A, Paltiel A, Zurakowski D, Treves S. Acute Scrotal Symptoms in Boys With an Indeterminate Clinical Presentation Investigative Urology 1998, 160: 1597-1598.. DOI: 10.1097/00005392-199810000-00157.
  • The Cost-Effectiveness of Preventing Cytomegalovirus Disease in AIDS PatientsPaltiel A, Freedberg K. The Cost-Effectiveness of Preventing Cytomegalovirus Disease in AIDS Patients Interfaces 1998, 28: 34-51. DOI: 10.1287/inte.28.3.34.
  • Resource Allocation and the Funding of HIV PreventionPaltiel A, Stinnett A. Resource Allocation and the Funding of HIV Prevention 1998, 135-152. DOI: 10.1007/978-1-4899-1878-9_10.
  • Making Health Policy Decisions: Is Human Instinct Rational? Is Rational Choice Human?Paltiel A, Stinnett A. Making Health Policy Decisions: Is Human Instinct Rational? Is Rational Choice Human? Chance 1996, 9: 34-39. DOI: 10.1080/09332480.1996.10555000.
  • Book reviewPaltiel A. Book review Policy Sciences 1992, 25: 77-79. DOI: 10.1007/bf00144634.
  • Nonrandom Mixing Models of HIV TransmissionKaplan E, Cramton P, Paltiel A. Nonrandom Mixing Models of HIV Transmission 1989, 83: 218-239. DOI: 10.1007/978-3-642-93454-4_10.